Discover trends, market shifts, and competitive outlooks for the biologics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Projected CAGR for the Biologics Market Size from 2025 to 2034?

In the past few years, there has been a swift expansion in the size of the biologics market. The market is poised to surge from a valuation of $533.36 billion in 2024 to an impressive $610.25 billion in 2025, growing at a compound annual growth rate (CAGR) of 14.4%. The historic growth trend can be owed to various factors such as the rising aging population, active government initiatives, the capacity to demand high prices, and the escalating requirement for immunology.

The biologics market is projected to experience a significant escalation in the ensuing years, anticipated to reach an evaluation of $1068.24 billion in 2029, with a compound annual growth rate (CAGR) of 15.0%. The predicted expansion in the forthcoming years can be ascribed to factors such as escalated funding, technological professionalization, improved healthcare accessibility, intensive research and development endeavors for the advancement of oral biologics, a preference towards pills as opposed to injections, and an increasingly strong pool of biologics in development. Key trends that are expected to dominate the forecast period involve capitalizing on modified and less restrictive regulations for the creation of superior biologics, the transition towards the development of biologic drugs, making investments in research and development for the creation of innovative biologics, and putting investment into the research and development of biologics for the treatment of intricate diseases.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3606&type=smp

What Are the Core Market Drivers Propelling Growth in the Biologics Industry?

The rising need for personalized medicine is propelling substantial growth in the global biologics market. With personalized medicine, also referred to as precision medicine, healthcare and medical treatments are tailored based on the unique attributes of each patient. This allows for the customization of biological therapies according to a patient’s distinct genetic and clinical profile, thereby bringing about a significant transformation in the healthcare sector. Consider, for example, in February 2024, the Personalized Medicine Coalition, an American hospital and healthcare organization, stated that in 2023, the FDA sanctioned 16 new personalized therapies for patients with rare diseases. This number rose sharply from six in 2022. Consequently, the escalating demand for personalized medicine is fostering the progress of the biologics market further.

How Is the Biologics Market Segmented?

The biologics market covered in this report is segmented –

1) By Type: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines

2) By Drug Classification: Branded Drugs, Generic Drugs

3) By Route Of Administration: Oral, Other Route Of Administration

4) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other Distribution Channels

Subsegments:

1) By Monoclonal Antibodies (MAbs): Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies

2) By Therapeutic Proteins: Hormones, Enzymes, Cytokines, Fusion Proteins

3) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, mRNA Vaccines, Viral Vector Vaccines

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3606&type=smp

Which Regions Are Driving the Next Phase of the Biologics Market Growth?

North America was the largest region in the biologics market in 2024. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Market Trends and Innovations Are Shaping the Future of the Biologics Industry?

Prominent firms in the biologics sector are putting their efforts on the creation of avant-garde products like oncology biosimilars, in order to consolidate their stance and obtain a strategic edge. Oncology biosimilars, a subset of biologic drug, are employed to treat cancer and are essentially undifferentiated versions of established biologic drugs. One such example is Abevmy, an oncology biosimilar, that was introduced in Canada in May 2022 by Biocon Biologics Limited- a branch of Biocon Limited, an Indian biopharmaceutical firm and Viatris Inc., an American pharmaceutical enterprise. Abevmy is a biosimilar medication used for cancer treatment. Biosimilar drugs are biological drugs that bear a high resemblance to already approved biological drugs and hence, are utilized to treat identical conditions as the original medicine with similar safety and efficacy.

View the full report here:

https://www.thebusinessresearchcompany.com/report/biologics-global-market-report

How Is the Biologics Market Defined and What Are Its Core Parameters?

Biologics are medications made from organic materials that can be used to treat a wide range of illnesses, and they are frequently used to treat immune-related illnesses. The interesting aspect is that biologics are separated from various natural sources, whether they be carbohydrates, proteins, nucleic acids, or a complex mixture of these materials.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3606

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model